Physician profile
Damieon Brown
NPI 1053335273
$12,344.50
in general payments reported to CMS, 2019-2025
30 companies · $7,003 in 2025
The $7,003 reported for 2025 was more than what 97% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,079 · 2020: $522 · 2021: $375 · 2022: $312 · 2023: $1,515 · 2024: $1,540 · 2025: $7,003.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,039 · Food and Beverage: $3,932 · Long Term Medical Supply Or Device Loan: $87.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,038.79 |
| Food and Beverage | $3,931.52 |
| Long Term Medical Supply Or Device Loan | $87.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,104.49 | 2019-2025 | Pico, Collagenase Santyl, Grafix |
| Mimedx Group, INC. | $2,703.23 | 2024-2025 | |
| Medline Industries LP | $1,593.07 | 2025 | |
| Kerecis Limited | $1,214.57 | 2021-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Smoky Mountain Surgical LLC | $765.37 | 2023-2024 | |
| Kci USA, INC. | $650.63 | 2019-2023 | Activ.A.C. |
| Arthrex, INC. | $485.80 | 2023 | |
| Musculoskeletal Transplant Foundation INC. | $254.79 | 2020 | |
| Organogenesis INC. | $235.04 | 2019-2021 | |
| Abbvie INC. | $169.79 | 2021-2025 | Dalvance |
| Osiris Therapeutics INC. | $148.79 | 2019 | |
| Bone Support INC. | $143.85 | 2024 | Ceramentbone Void Filler, Cerament G |
| Paratek Pharmaceuticals, INC. | $123.92 | 2022-2025 | Nuzyra |
| Bsn Medical INC | $121.98 | 2024 | |
| Integra Lifesciences Corporation | $116.44 | 2024 | Acell, Integra, Integra Dermal Regeneration Template |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocomposites INC | $103.86 | 2025 | Stimulan |
| Medartis INC. | $75.88 | 2020 | |
| Treace Medical Concepts, INC. | $56.86 | 2022 | |
| Polymedics Innovations INC. | $55.30 | 2025 | |
| Hartmann USA, INC. | $36.58 | 2021 | |
| Triad Life Sciences INC. | $33.65 | 2022 | |
| Xeris Pharmaceuticals, INC. | $23.64 | 2023 | Gvoke Hypopen |
| Lifenet Health | $20.75 | 2023 | |
| Molnlycke Health Care US, LLC | $17.39 | 2022 | |
| Convatec INC. | $17.33 | 2022 | |
| Philips North America LLC | $16.20 | 2022 | |
| Urgo Medical North America, LLC | $15.96 | 2024 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Alpha Orthopedic Systems | $14.23 | 2022 | |
| Hydrofera LLC | $13.95 | 2022 | |
| Ovik Health, LLC | $11.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Damieon Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.